GENE ONLINE|News &
Opinion
Blog

FDA Approval
Wegovy Expands Its Reach: First Weight-Loss Medication Approved to Reduce Cardiovascular Risk
2024-03-11
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
FDA Approves First Treatment for Fibrodysplasia Ossificans Progressiva
2023-08-21
FDA Approves GSK’s PD-1 Medicine for Early-Detected Endometrial Cancer
2023-08-06
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
The First Non-prescription Oral Contraceptive approved by FDA
2023-07-18
FDA Approves Pfizer’s Human Growth Hormone Drug
2023-07-03
Recent Highlights of the RSV Vaccine Battle, with More Regulatory Approvals in Sight
2023-06-08
GSK Wins Approval For World’s First RSV Vaccine
2023-05-08
Nestle and Seres Land First-Ever Fecal Microbiota Product Approval From FDA
2023-04-27
FDA Grants Biogen’s Ultra-Rare ALS Med Accelerated Approval
2023-04-26
Gamida’s Allogeneic Cell Therapy Snags FDA Approval for Blood Cancers
2023-04-18
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Reata’s Groundbreaking Therapy for an Ultra-rare Neuromuscular Disease Secures FDA Approval
2023-03-02
1 2 3 9
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top